The FDA has declined Moderna's request for review of their mRNA flu vaccine, stymieing a path to approval for using the vaccine in the U.S.; that's a fact.
I can't verify the follow-on yet; the only source is a single user on "X" (formerly Twitter), Leah Libresco Sargeant, who claims, "Moderna's CEO announced the company will no longer invest in new Phase 3 vaccine trials for infectious diseases...," sidelining develpment of mRNA vaccines for Epstein-Barr virus, shingles and herpes because without access to the U.S. market, the effort is likely to lose money.
Big if true, and a real loss for humanity. Moderna's a for-profit corporation, not a charity, and they didn't make the rules: if the corporation doesn't make money for its investors, the investors stop investing.
The flu vaccine rejection is a direct result of RFK, Jr's thumb on the scales. A successful vaccine is almost literally a "better mousetrap," and Moderna's track record is good -- not a sure thing, but about as close as it gets. Americans voted for this, and the Senate didn't stop it.
UPDATE: the quote looks legitimate; the original source appears to be a (paywalled, scroll quickly!) Bloomberg News article, itself quoted in Biospace, which was linked to by a piece at Marginal Revolution. That's as much as I've found.
No comments:
Post a Comment
Comment moderation is enabled. Your comment will not be visible until approved. Arguing or use of insulting or derogatory language will result in your comment going unpublished: no name-calling. Comments I deem excessively partisan will not be published. "Unknown" or "Anonymous" comments are unlikely to be published.